Delivery Order SPE2DB22D2006-SPE2DB25FW3AJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order valued at $5,984.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $8,102.57. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $13,755.84. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services under...
- This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Rifampin 300 mg capsules, a critical antibiotic medication, to support military treatment facilities and other federal healthcare providers. The contract has a ceiling value of $18,609.46 and an ultimate completion date of August 29, 2024. It is a firm-fixed-price contract, with no set-aside designation....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count). This firm fixed-price contract, valued at $2,602.40, represents a non-competitive award and is scheduled for completion by July 31, 2025. The pharmaceutical product will be performed and delivered from the contractor's Conshohocken facility. This delivery order is issued under...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin Capsules under a firm fixed-price contract valued at $358,753.20. The contract, which carries no set-aside designation, is effective through July 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic medication used in the treatment of tuberculosis and other mycobacterial...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for the supply of Rifampin 150 mg capsules (30-count) on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract employs firm fixed price terms and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Rifampin 300 mg capsules. The firm-fixed-price contract has a ceiling value of $10,688.90 and a completion date of November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3AJDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,089.08. The contract is firm fixed price with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025, with no set-aside designation. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The Rifampin delivery order supports the DLA's ongoing pharmaceutical supply requirements for military healthcare systems. Rifampin is an essential antibiotic used in the treatment of tuberculosis and certain other infections, making it a critical component of military medical readiness. As a child contract under the SPE2DX prime contract vehicle, this delivery order leverages AmerisourceBergen's capability to supply a comprehensive range of pharmaceutical products and medical commodities to support Defense Health Agency operations and other federal healthcare systems worldwide. The competitive award reflects the contractor's demonstrated ability to meet federal procurement requirements for specialized pharmaceutical products on a firm fixed price basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/31/25 |